ЭФФЕКТИВНОСТЬ ЛЕЧЕНИЯ МУЛЬТИРЕЗИСТЕНТНОГО ТУБЕРКУЛЕЗА ПО IV/V РЕЖИМАМ ХИМИОТЕРАПИИ С ВКЛЮЧЕНИЕМ БЕДАКВИЛИНА

Tuberculosis as a social human disease has been known since ancient times. Morbidity and mortality from multidrug-resistant TB (MDR-TB) extensively drug-resistant (XDR-TB) both in RS(Y) the Russian Federation remain high. In recent years, studies have conducted on effectiveness of chemotherapy using drug bedaquiline. State Budgetary Institution Republic Sakha (Yakutia) SPC “Phthisiology”, prescription bedaquiline to patients with MDR XDR-TB IV/V RCT started 2019. The purpose article is evaluate effect treating tuberculosis inclusion newly diagnosed respiratory tuberculosis. material method study were 80 pulmonary multiple extensive resistance, determined by susceptibility testing nutrient media molecular genetic methods. considers characteristic description clinical forms treatment. As result, it was found that when included standard IV V regimen, there high efficiency treatment short time no undesirable side reactions. Statistical processing obtained data carried out statistical programs.